BMY R&D Expense Growth
Bristol Myers Squibb · R&D Expense Growth

BMY R&D Expense Growth
Latest reported-10.83%period ending
BMY FY R&D Growth (YoY) (0.00% → -10.83%)
Latest values, visible window
High-resolution chart · PNG
BMY r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -10.8253% | |
| 20.0022% | |
| -2.2084% | |
| -6.7288% | |
| -8.5076% | |
| 81.2459% | |
| -2.9059% | |
| -2.1027% | |
| 29.0503% | |
| -15.3378% | |
| 30.569% | |
| 21.5224% | |
| -4.4314% | |
| 1.6931% | |
| 7.6556% | |
| -2.221% | |
| 3.844% | |
| 7.0079% | |
| 9.7292% | |
| 11.6878% | |
| 7.12% | |
| 9.6972% | |
| 3.3092% | |
| 1.0536% | |
| 12.5838% | |
| 10.2331% | |
| 16.7995% | |
| 8.7365% | |
| 8.5423% | |
| 6.422% | |
| 8.213% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |